This topic contains a solution. Click here to go to the answer

Author Question: In the figure above, the shift in the supply of loanable funds curve from SLF1 to SLF2 could be the ... (Read 74 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
In the figure above, the shift in the supply of loanable funds curve from SLF1 to SLF2 could be the result of
 
  A) an increase in expected rate of profit.
  B) a decrease in disposable income.
  C) an increase in expected future disposable income.
  D) an increase in the real interest rate.
  E) a decrease in wealth

Question 2

Suppose an economy has no income taxes or imports. If the MPC is 0.75, what does the expenditure multiplier equal?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ansleighelindsey

  • Sr. Member
  • ****
  • Posts: 364
Answer to Question 1

E

Answer to Question 2

The expenditure multiplier equals , so in this case it equals = = 4.0.




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jun 29, 2018
Great answer, keep it coming :)


Sarahjh

  • Member
  • Posts: 370
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library